Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Futura Medical (FUM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
35.65 +0.15    +0.42%
19/04 - Closed. Currency in GBP ( Disclaimer )
  • Volume: 425,707
  • Bid/Ask: 35.30 / 60.00
  • Day's Range: 34.05 - 36.50
Type:  Equity
Market:  United Kingdom
ISIN:  GB0033278473 
SEDOL:  3327847
Futura 35.65 +0.15 +0.42%

FUM Balance Sheet

 
Assess the latest Futura balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced FUM Annual Report data, financial summaries and charts are available for Futura Medical investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets - - 9.11 9.11
Cash and Short Term Investments - - 7.84 7.84
Cash - - - -
Cash & Equivalents - - 7.84 7.84
Short Term Investments - - - -
Total Receivables, Net 1.52 1.52 1.2 1.2
Accounts Receivables - Trade, Net 1.15 1.15 0.995 0.995
Total Inventory - - 0.001 0.001
Prepaid Expenses 0.092 0.092 0.065 0.065
Other Current Assets, Total - - - -
Total Assets - - 10.21 10.21
Property/Plant/Equipment, Total - Net - - 1.1 1.1
Property/Plant/Equipment, Total - Gross 2.8 2.8 - -
Accumulated Depreciation, Total -0.316 -0.316 - -
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments - - - -
Note Receivable - Long Term - - 0.208 0.208
Other Long Term Assets, Total - - - -
Other Assets, Total -1.52 -1.52 -1.2 -1.2
Total Current Liabilities - - 2.2 2.2
Accounts Payable 1.01 1.01 0.675 0.675
Payable/Accrued - - - -
Accrued Expenses 1.49 1.49 0.876 0.876
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 3.85 3.85 0.644 0.644
Total Liabilities - - 2.2 2.2
Total Long Term Debt - - - -
Long Term Debt - - - -
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total - - - -
Total Equity - - 8.01 8.01
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - - 0.598 0.598
Additional Paid-In Capital - - 70.93 70.93
Retained Earnings (Accumulated Deficit) - - -64.67 -64.67
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - - 1.15 1.15
Total Liabilities & Shareholders' Equity - - 10.21 10.21
Total Common Shares Outstanding 301.41 301.41 299.07 299.07
Total Preferred Shares Outstanding - - - -
* In Millions of GBP (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

FUM Price Commentary

Write your thoughts about Futura Medical
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
S A PARKER
S A PARKER Nov 03, 2023 8:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2 November 2023 Futura Medical plc ("Futura" or the "Company") Eroxon Awarded "New Product of the Year, Healthcare" by Boots
S A PARKER
S A PARKER Nov 03, 2023 8:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2 Nov 2023 15:34 RNS Number : 2422S Futura Medical PLC 02 November 2023 2 November 2023 Futura Medical plc ("Futura" or the "Company") Eroxon Awarded "New Product of the Year, Healthcare" by Boots Futura Medical plc (AIM: FUM) ("Futura" or the "Company"), the pharmaceutical company developing innovative sexual health products, announces that Eroxon® has won the "New Product of the Year, Healthcare" category at the Boots Supplier Awards 2023, following its UK launch earlier this year. The award is further recognition for Futura's breakthrough treatment for erectile dysfunction ("ED") as it provides an alternative treatment option for the 4.3 million men in the UK experiencing symptoms*.
Tim Smith
Tim Smith Oct 31, 2023 18:07
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What the heck has happened to this share? Was doing ok and then it's just dropped over 50%
Mark Hamilton
Mark Hamilton Sep 06, 2022 5:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This going steadily climb then explode in price on 27th...... profits will pay my gas bill 💵 this winter 🥶
Andrew Barton
Andrew Barton Aug 26, 2022 11:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
US trial results due anytime now. There seems to be some anticipation building in the stock chart trend.
Luciano Pereira
Luciano Pereira Sep 02, 2021 19:16
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any news on why the EU Approval Certification is taking so long?
Mark Hamilton
Mark Hamilton Sep 02, 2021 19:16
Saved. See Saved Items.
This comment has already been saved in your Saved Items
covid restrictions apply and hampper testing facilities no doubt
Andrew Barton
Andrew Barton Sep 02, 2021 19:16
Saved. See Saved Items.
This comment has already been saved in your Saved Items
EU UK approval is in place. Now in the commercialisation phase.
Andrew Barton
Andrew Barton Sep 02, 2021 19:16
Saved. See Saved Items.
This comment has already been saved in your Saved Items
(LON:FUM) AGM Statement from the pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain. MED3000 CE mark approved for marketing in Europe and UK; Commercialisation of MED3000 continues at pace with China and South East Asia partnered and discussions for other countries ongoing;
Richard Chapman
Richard Chapman Apr 30, 2021 8:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
More positive news today
Jude Singleton
Jude Singleton Apr 07, 2021 12:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will this not go up again until we see revenues start to come in, which could be months?
Nick Dawood
Nick Dawood Apr 07, 2021 12:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think 50-60p range until the next news comes in. Next news will be receiving the EU Approval Certificate which is due anytime in the next 6 weeks. Just be patient
Jude Singleton
Jude Singleton Apr 07, 2021 12:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
thanks, i bought in near the top so i am trying to work out where the bottom is to lower my average, but it looks like it could go back to the 40s. maybe i will get a bit more at 50
Nick Dawood
Nick Dawood Apr 07, 2021 12:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Possibly may go into the late 40’s. Would be a good entry point if it goes. I can honestly see this up near £1 in the next few months. Time will tell. Good luck
Paul Fay
Paul Fay Apr 07, 2021 12:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time did tell. 😢
Smooth Operator
Smooth_Operator Mar 22, 2021 16:05
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will pull back down
Bu Bee
Bu Bee Mar 22, 2021 16:05
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why? any news?
Jan Mar H
Jan Mar H Mar 22, 2021 14:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
100p soon! Buy!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email